Inbound Relationships |
Type |
Active |
Source |
Characteristic |
Refinability |
Group |
Ofloxacin measurement |
Component |
True |
Ofloxacin (substance) |
Inferred relationship |
Some |
1 |
Ofloxacin adverse reaction |
Causative agent (attribute) |
True |
Ofloxacin (substance) |
Inferred relationship |
Some |
1 |
Allergy to ofloxacin |
Causative agent (attribute) |
False |
Ofloxacin (substance) |
Inferred relationship |
Some |
|
Ofloxacin 200 mg oral tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Ofloxacin (substance) |
Inferred relationship |
Some |
|
Ofloxacin 2mg/mL infusion solution 100mL vial |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Ofloxacin (substance) |
Inferred relationship |
Some |
|
Ofloxacin 2mg/mL infusion solution 50mL vial |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Ofloxacin (substance) |
Inferred relationship |
Some |
|
Ofloxacin 400 mg oral tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Ofloxacin (substance) |
Inferred relationship |
Some |
|
Ofloxacin [eye] |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Ofloxacin (substance) |
Inferred relationship |
Some |
|
Product containing precisely ofloxacin 3 milligram/1 milliliter conventional release eye drops (clinical drug) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Ofloxacin (substance) |
Inferred relationship |
Some |
|
Ofloxacin 4mg/mL infusion solution 50mL bag |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Ofloxacin (substance) |
Inferred relationship |
Some |
|
Ofloxacin 40mg/mL injection solution 10mL vial |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Ofloxacin (substance) |
Inferred relationship |
Some |
|
Ofloxacin 4mg/mL infusion solution 100mL bag |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Ofloxacin (substance) |
Inferred relationship |
Some |
|
Ofloxacin 300 mg oral tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Ofloxacin (substance) |
Inferred relationship |
Some |
|
Product containing precisely ofloxacin 3 milligram/1 milliliter conventional release ear solution (clinical drug) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Ofloxacin (substance) |
Inferred relationship |
Some |
|
Ofloxacin 3mg/mL solution |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Ofloxacin (substance) |
Inferred relationship |
Some |
|
Ofloxacin-containing product in oral dose form |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Ofloxacin (substance) |
Inferred relationship |
Some |
1 |
Ofloxacin-containing product in parenteral dose form |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Ofloxacin (substance) |
Inferred relationship |
Some |
1 |
Product containing ofloxacin in ocular dose form (medicinal product form) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Ofloxacin (substance) |
Inferred relationship |
Some |
1 |
Product containing ofloxacin in otic dose form (medicinal product form) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Ofloxacin (substance) |
Inferred relationship |
Some |
1 |
Product containing ofloxacin (medicinal product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Ofloxacin (substance) |
Inferred relationship |
Some |
1 |
Ofloxacin hydrochloride |
Is a |
False |
Ofloxacin (substance) |
Inferred relationship |
Some |
|
Allergy to ofloxacin |
Causative agent (attribute) |
True |
Ofloxacin (substance) |
Inferred relationship |
Some |
1 |
Ofloxacin 200 mg oral tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Ofloxacin (substance) |
Inferred relationship |
Some |
1 |
Ofloxacin 200 mg oral tablet |
This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. |
True |
Ofloxacin (substance) |
Inferred relationship |
Some |
1 |
Ofloxacin 400 mg oral tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Ofloxacin (substance) |
Inferred relationship |
Some |
1 |
Ofloxacin 400 mg oral tablet |
This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. |
True |
Ofloxacin (substance) |
Inferred relationship |
Some |
1 |
Ofloxacin 300 mg oral tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Ofloxacin (substance) |
Inferred relationship |
Some |
1 |
Ofloxacin 300 mg oral tablet |
This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. |
True |
Ofloxacin (substance) |
Inferred relationship |
Some |
1 |
Ofloxacin 200 mg oral tablet |
The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). |
True |
Ofloxacin (substance) |
Inferred relationship |
Some |
1 |
Ofloxacin 400 mg oral tablet |
The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). |
True |
Ofloxacin (substance) |
Inferred relationship |
Some |
1 |
Ofloxacin 300 mg oral tablet |
The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). |
True |
Ofloxacin (substance) |
Inferred relationship |
Some |
1 |
Ofloxacin hydrochloride |
This attribute indicates that the concept is a structural modification of another concept, and that the substance's intrinsic physicochemical properties remain unchanged. |
True |
Ofloxacin (substance) |
Inferred relationship |
Some |
|
Product containing precisely ofloxacin 3 milligram/1 milliliter conventional release eye drops (clinical drug) |
This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. |
True |
Ofloxacin (substance) |
Inferred relationship |
Some |
1 |
Product containing precisely ofloxacin 3 milligram/1 milliliter conventional release eye drops (clinical drug) |
The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). |
True |
Ofloxacin (substance) |
Inferred relationship |
Some |
1 |
Product containing precisely ofloxacin (as ofloxacin hydrochloride) 200 milligram/100 milliliter conventional release solution for infusion bottle |
This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. |
False |
Ofloxacin (substance) |
Inferred relationship |
Some |
1 |
Product containing precisely ofloxacin 100 milligram/50 milliliter conventional release solution for infusion bottle |
The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). |
False |
Ofloxacin (substance) |
Inferred relationship |
Some |
1 |
Product containing precisely ofloxacin 100 milligram/50 milliliter conventional release solution for infusion bottle |
This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. |
False |
Ofloxacin (substance) |
Inferred relationship |
Some |
1 |
Product containing only ofloxacin (medicinal product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Ofloxacin (substance) |
Inferred relationship |
Some |
1 |
Ofloxacin only product in ocular dose form |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Ofloxacin (substance) |
Inferred relationship |
Some |
1 |
Product containing only ofloxacin in oral dose form (medicinal product form) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Ofloxacin (substance) |
Inferred relationship |
Some |
1 |
Product containing only ofloxacin in otic dose form (medicinal product form) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Ofloxacin (substance) |
Inferred relationship |
Some |
1 |
Ofloxacin only product in parenteral dose form |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Ofloxacin (substance) |
Inferred relationship |
Some |
1 |
Product containing precisely ofloxacin 2 milligram/1 milliliter conventional release solution for infusion (clinical drug) |
This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. |
True |
Ofloxacin (substance) |
Inferred relationship |
Some |
1 |
Product containing precisely ofloxacin 2 milligram/1 milliliter conventional release solution for infusion (clinical drug) |
The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). |
True |
Ofloxacin (substance) |
Inferred relationship |
Some |
1 |
Ofloxacin (as ofloxacin hydrochloride) 2 mg/mL solution for infusion |
This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. |
True |
Ofloxacin (substance) |
Inferred relationship |
Some |
1 |
Product containing precisely ofloxacin 3 milligram/1 milliliter conventional release ear solution (clinical drug) |
The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). |
True |
Ofloxacin (substance) |
Inferred relationship |
Some |
1 |
Product containing precisely ofloxacin 3 milligram/1 milliliter conventional release ear solution (clinical drug) |
This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. |
True |
Ofloxacin (substance) |
Inferred relationship |
Some |
1 |
Product containing precisely ofloxacin 2 milligram/1 milliliter conventional release solution for injection (clinical drug) |
The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). |
True |
Ofloxacin (substance) |
Inferred relationship |
Some |
1 |
Product containing precisely ofloxacin 2 milligram/1 milliliter conventional release solution for injection (clinical drug) |
This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. |
True |
Ofloxacin (substance) |
Inferred relationship |
Some |
1 |
Ofloxacin (as ofloxacin hydrochloride) 2 mg/mL solution for injection |
This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. |
True |
Ofloxacin (substance) |
Inferred relationship |
Some |
1 |
Product containing precisely dexamethasone (as dexamethasone sodium phosphate) 1 milligram/1 milliliter and ofloxacin 3 milligram/1 milliliter conventional release eye drops (clinical drug) |
The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). |
True |
Ofloxacin (substance) |
Inferred relationship |
Some |
2 |
Product containing precisely dexamethasone (as dexamethasone sodium phosphate) 1 milligram/1 milliliter and ofloxacin 3 milligram/1 milliliter conventional release eye drops (clinical drug) |
This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. |
True |
Ofloxacin (substance) |
Inferred relationship |
Some |
2 |
Product containing only dexamethasone and ofloxacin (medicinal product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Ofloxacin (substance) |
Inferred relationship |
Some |
2 |
Product containing only dexamethasone and ofloxacin in ocular dose form (medicinal product form) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Ofloxacin (substance) |
Inferred relationship |
Some |
2 |
Product containing dexamethasone and ofloxacin (medicinal product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Ofloxacin (substance) |
Inferred relationship |
Some |
2 |
Product containing dexamethasone and ofloxacin in ocular dose form (medicinal product form) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Ofloxacin (substance) |
Inferred relationship |
Some |
2 |
Product containing ofloxacin and tinidazole (medicinal product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Ofloxacin (substance) |
Inferred relationship |
Some |
1 |
Product containing only ofloxacin and tinidazole (medicinal product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Ofloxacin (substance) |
Inferred relationship |
Some |
1 |
Product containing ofloxacin and tinidazole in oral dose form (medicinal product form) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Ofloxacin (substance) |
Inferred relationship |
Some |
1 |
Product containing only ofloxacin and tinidazole in oral dose form (medicinal product form) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Ofloxacin (substance) |
Inferred relationship |
Some |
1 |
Ofloxacin 200 mg and tinidazole 600 mg oral tablet |
The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). |
True |
Ofloxacin (substance) |
Inferred relationship |
Some |
1 |
Ofloxacin 200 mg and tinidazole 600 mg oral tablet |
This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. |
True |
Ofloxacin (substance) |
Inferred relationship |
Some |
1 |
Product containing precisely ofloxacin 10 milligram/1 milliliter conventional release oral suspension (clinical drug) |
The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). |
True |
Ofloxacin (substance) |
Inferred relationship |
Some |
1 |
Product containing precisely ofloxacin 10 milligram/1 milliliter conventional release oral suspension (clinical drug) |
This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. |
True |
Ofloxacin (substance) |
Inferred relationship |
Some |
1 |
Product containing precisely ofloxacin 200 milligram and ornidazole 500 milligram/1 each conventional release oral tablet (clinical drug) |
The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). |
True |
Ofloxacin (substance) |
Inferred relationship |
Some |
1 |
Product containing precisely ofloxacin 200 milligram and ornidazole 500 milligram/1 each conventional release oral tablet (clinical drug) |
This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. |
True |
Ofloxacin (substance) |
Inferred relationship |
Some |
1 |
Product containing only ofloxacin and ornidazole (medicinal product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Ofloxacin (substance) |
Inferred relationship |
Some |
1 |
Ofloxacin and ornidazole only product in oral dose form |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Ofloxacin (substance) |
Inferred relationship |
Some |
1 |
Ofloxacin- and ornidazole-containing product in oral dose form |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Ofloxacin (substance) |
Inferred relationship |
Some |
1 |
Product containing ofloxacin and ornidazole (medicinal product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Ofloxacin (substance) |
Inferred relationship |
Some |
1 |
Product containing precisely ofloxacin (as ofloxacin hydrochloride) 2 milligram/1 milliliter conventional release solution for infusion and/or injection (clinical drug) |
This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. |
True |
Ofloxacin (substance) |
Inferred relationship |
Some |
1 |
Product containing only cefixime and ofloxacin (medicinal product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Ofloxacin (substance) |
Inferred relationship |
Some |
2 |
Cefixime- and ofloxacin-containing product |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Ofloxacin (substance) |
Inferred relationship |
Some |
2 |
Product containing only cefixime and ofloxacin in oral dose form (medicinal product form) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Ofloxacin (substance) |
Inferred relationship |
Some |
2 |
Cefixime- and ofloxacin-containing product in oral dose form |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Ofloxacin (substance) |
Inferred relationship |
Some |
2 |
Product containing precisely cefixime 100 milligram and ofloxacin 100 milligram/1 each tablet for conventional release oral suspension (clinical drug) |
The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). |
True |
Ofloxacin (substance) |
Inferred relationship |
Some |
2 |
Product containing precisely cefixime 100 milligram and ofloxacin 100 milligram/1 each tablet for conventional release oral suspension (clinical drug) |
This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. |
True |
Ofloxacin (substance) |
Inferred relationship |
Some |
2 |
Ofloxacin 2 mg/mL solution for infusion and/or injection |
The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). |
True |
Ofloxacin (substance) |
Inferred relationship |
Some |
1 |
Ofloxacin 2 mg/mL solution for infusion and/or injection |
This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. |
True |
Ofloxacin (substance) |
Inferred relationship |
Some |
1 |